サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1370428

がんバイオマーカー市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Cancer Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 147 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
がんバイオマーカー市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

市場概要：

世界のがんバイオマーカー市場規模は2022年に247億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに537億米ドルに達し、2023年から2028年の間に12.95%の成長率（CAGR）を示すと予測しています。

がんバイオマーカーは、血液、組織、体液中にがん細胞が存在することを示す生物学的分子です。バイオマーカーは、がん細胞自体によって産生されることもあれば、がんに反応して体内の他の組織によって産生されることもあります。一般的ながんには、乳がん、前立腺がん、子宮頸がん、肺がん、大腸がんなどがあります。これらは病気の診断、進行のモニタリング、浸潤性腫瘍と非浸潤性腫瘍の区別、再発の可能性の予測、治療効果の記録などに広く用いられています。酵素、タンパク質、核酸、遺伝子、特定の細胞、ペプチドなどが一般的なバイオマーカーです。その結果、バイオマーカーは予後予測、代替エンドポイント、診断、個別化医薬品として広く利用されています。

がんバイオマーカー市場の動向：

世界中でがんの有病率が増加しており、市場の見通しは明るいです。バイオマーカーは、がんの早期発見や治療・管理中に、転帰を正確かつ確実に予測するために広く利用されています。これに伴い、汚染レベルの上昇、喫煙動向、摂取習慣の悪化による肺がん罹患率の増加が、市場の成長を増大させています。さらに、次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、遺伝子発現プロファイリング（マイクロアレイ）、治療後のがん再発予測を支援する人工知能（AI）など、遺伝子バイオマーカー探索におけるさまざまな技術進歩が、市場成長に弾みをつけています。さらに、早期診断の重要性に対するヘルスケア専門家や患者の意識の高まりや、標準的な診断法の欠如によるがん治療の個別化医療への大きなシフトが、市場成長に好影響を与えています。その他の要因としては、ヘルスケア産業の著しい成長、広範な研究開発（R&D）活動、医薬品開発プロセス強化のための様々な政府イニシアチブの実施などが挙げられ、これらは市場の成長を後押しすると予想されます。

本レポートで扱う主な質問

  • 2022年の世界のがんバイオマーカー市場規模は？
  • 2023～2028年の世界のがんバイオマーカー市場の予想成長率は？
  • 世界のがんバイオマーカー市場を牽引する主要因は何か？
  • COVID-19が世界のがんバイオマーカー市場に与えた影響は？
  • 生体分子に基づく世界のがんバイオマーカー市場の内訳は？
  • がんタイプ類に基づくがんバイオマーカーの世界市場の内訳は？
  • がんバイオマーカーの世界市場における主要地域は？
  • がんバイオマーカーの世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 がんバイオマーカーの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：プロファイリング技術別

  • オミクス技術
    • 市場動向
    • 市場予測
  • イメージング技術
    • 市場動向
    • 市場予測
  • イムノアッセイ
    • 市場動向
    • 市場予測
  • 細胞遺伝学
    • 市場動向
    • 市場予測

第7章 市場内訳：生体分子別

  • 遺伝子バイオマーカー
    • 市場動向
    • 市場予測
  • タンパク質バイオマーカー
    • 市場動向
    • 市場予測
  • 糖質バイオマーカー
    • 市場動向
    • 市場予測

第8章 市場内訳：がんタイプ別

  • 乳がん
    • 市場動向
    • 市場予測
  • 肺がん
    • 市場動向
    • 市場予測
  • 大腸がん
    • 市場動向
    • 市場予測
  • 前立腺がん
    • 市場動向
    • 市場予測
  • 胃がん
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：用途別

  • 診断薬
    • 市場動向
    • 市場予測
  • プログノスティックス
    • 市場動向
    • 市場予測
  • リスク評価
    • 市場動向
    • 市場予測
  • 創薬と医薬品開発
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 学術・研究機関
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • 診断ラボ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • bioMerieux SA
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • Illumina Inc.
    • Qiagen N.V.
    • Sino Biological Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Cancer Biomarkers Market: Major Drivers and Challenges
  • Figure 2: Global: Cancer Biomarkers Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Cancer Biomarkers Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Cancer Biomarkers Market: Breakup by Profiling Technology (in %), 2022
  • Figure 5: Global: Cancer Biomarkers Market: Breakup by Biomolecule (in %), 2022
  • Figure 6: Global: Cancer Biomarkers Market: Breakup by Cancer Type (in %), 2022
  • Figure 7: Global: Cancer Biomarkers Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Cancer Biomarkers Market: Breakup by End User (in %), 2022
  • Figure 9: Global: Cancer Biomarkers Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Cancer Biomarkers (Omic Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Cancer Biomarkers (Omic Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Cancer Biomarkers (Imaging Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Cancer Biomarkers (Imaging Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Cancer Biomarkers (Immunoassays) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Cancer Biomarkers (Immunoassays) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Cancer Biomarkers (Cytogenetics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Cancer Biomarkers (Cytogenetics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Cancer Biomarkers (Genetic Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Cancer Biomarkers (Genetic Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Cancer Biomarkers (Protein Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Cancer Biomarkers (Protein Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Cancer Biomarkers (Glyco-Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Cancer Biomarkers (Glyco-Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Cancer Biomarkers (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Cancer Biomarkers (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Cancer Biomarkers (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Cancer Biomarkers (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Cancer Biomarkers (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Cancer Biomarkers (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Cancer Biomarkers (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Cancer Biomarkers (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Cancer Biomarkers (Stomach Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Cancer Biomarkers (Stomach Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Cancer Biomarkers (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Cancer Biomarkers (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Cancer Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Cancer Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Cancer Biomarkers (Prognostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Cancer Biomarkers (Prognostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Cancer Biomarkers (Risk Assessment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Cancer Biomarkers (Risk Assessment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Cancer Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Cancer Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Global: Cancer Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Global: Cancer Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Global: Cancer Biomarkers (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Global: Cancer Biomarkers (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Global: Cancer Biomarkers (Academic and Research Institutions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Global: Cancer Biomarkers (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Global: Cancer Biomarkers (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Global: Cancer Biomarkers (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Global: Cancer Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Global: Cancer Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: North America: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: North America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United States: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United States: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Canada: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Canada: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Asia-Pacific: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Asia-Pacific: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: China: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: China: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Japan: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Japan: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: India: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: India: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: South Korea: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: South Korea: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Australia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Australia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Indonesia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Indonesia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Europe: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Europe: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Germany: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Germany: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: France: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: France: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: United Kingdom: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: United Kingdom: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Italy: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Italy: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Spain: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Spain: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Russia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Russia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 93: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Latin America: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 95: Latin America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 96: Brazil: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 97: Brazil: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 98: Mexico: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 99: Mexico: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 100: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 101: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 102: Middle East and Africa: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 103: Middle East and Africa: Cancer Biomarkers Market: Breakup by Country (in %), 2022
  • Figure 104: Middle East and Africa: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 105: Global: Cancer Biomarkers Industry: SWOT Analysis
  • Figure 106: Global: Cancer Biomarkers Industry: Value Chain Analysis
  • Figure 107: Global: Cancer Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cancer Biomarkers Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Cancer Biomarkers Market Forecast: Breakup by Profiling Technology (in Million US$), 2023-2028
  • Table 3: Global: Cancer Biomarkers Market Forecast: Breakup by Biomolecule (in Million US$), 2023-2028
  • Table 4: Global: Cancer Biomarkers Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
  • Table 5: Global: Cancer Biomarkers Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Cancer Biomarkers Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 7: Global: Cancer Biomarkers Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Cancer Biomarkers Market: Competitive Structure
  • Table 9: Global: Cancer Biomarkers Market: Key Players
目次
Product Code: SR112023A5834

Abstract

Market Overview:

The global cancer biomarkers market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 53.7 Billion by 2028, exhibiting a growth rate (CAGR) of 12.95% during 2023-2028.

Cancer biomarkers are biological molecules that indicate the presence of cancerous cells in the blood, tissues or other fluids of the body. They can be produced by the cancer cell itself or by other tissues in the body in response to cancer. Some common forms of cancer include breast, prostate, cervical, lung, and colorectal cancer. They are widely used for diagnosing the disease, monitoring their progression, distinguishing between invasive and non-invasive tumors, predicting the chances of recurrences and recording therapeutic treatment efficacy. Enzymes, proteins, nucleic acids, genes, specific cells. and peptides are some of the common types of biomarkers. As a result, they are widely used as prognostics, surrogate endpoints, diagnostics, and personalized medicines.

Cancer Biomarkers Market Trends:

The increasing prevalence of cancer across the globe is creating a positive outlook for the market. Biomarkers are widely used for early cancer detection and during treatment and management to accurately and reliably predict outcomes. In line with this, the increasing incidences of lung cancer due to the upsurge in pollution levels, smoking trends and poor ingestion habits is augmenting the market growth. Moreover, various technological advancements in genetic biomarker discovery, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), gene expression profiling (microarray), and the artificial inelegance (AI) that assist in predicting the recurrence of cancer after treatment, are providing an impetus to the market growth. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early diagnosis and the significant shift toward personalized medicine for cancer treatment due to the lack of standard diagnosis is favoring the market growth. Other factors, including the significant growth in the healthcare industry, extensive research and development (R&D) activities and the implementation of various government initiatives for enhancing the drug development processes, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer biomarkers market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on profiling technology, biomolecule, cancer type, application and end user.

Breakup by Profiling Technology:

Omic Technologies

Imaging Technologies

Immunoassays

Cytogenetics

Breakup by Biomolecule:

Genetic Biomarkers

Protein Biomarkers

Glyco-Biomarkers

Breakup by Cancer Type:

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Stomach Cancer

Others

Breakup by Application:

Diagnostics

Prognostics

Risk Assessment

Drug Discovery and Development

Others

Breakup by End User:

Hospitals

Academic and Research Institutions

Ambulatory Surgical Centers

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Qiagen N.V., Sino Biological Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global cancer biomarkers market in 2022?
  • 2. What is the expected growth rate of the global cancer biomarkers market during 2023-2028?
  • 3. What are the key factors driving the global cancer biomarkers market?
  • 4. What has been the impact of COVID-19 on the global cancer biomarkers market?
  • 5. What is the breakup of the global cancer biomarkers market based on the biomolecule?
  • 6. What is the breakup of the global cancer biomarkers market based on the cancer type?
  • 7. What are the key regions in the global cancer biomarkers market?
  • 8. Who are the key players/companies in the global cancer biomarkers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cancer Biomarkers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Profiling Technology

  • 6.1 Omic Technologies
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Imaging Technologies
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Immunoassays
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cytogenetics
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Biomolecule

  • 7.1 Genetic Biomarkers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Protein Biomarkers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Glyco-Biomarkers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Cancer Type

  • 8.1 Breast Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Lung Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Colorectal Cancer
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Stomach Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Diagnostics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Prognostics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Risk Assessment
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Drug Discovery and Development
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Academic and Research Institutions
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Ambulatory Surgical Centers
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Diagnostic Laboratories
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Agilent Technologies Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Becton Dickinson and Company
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 bioMerieux SA
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Danaher Corporation
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 F. Hoffmann-La Roche AG
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 SWOT Analysis
    • 16.3.7 General Electric Company
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Illumina Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Qiagen N.V.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Sino Biological Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Thermo Fisher Scientific Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis